Paula J. Olsiewski is an American biochemist who is a Contributing Scholar at the Johns Hopkins Center for Health Security.
Olsiewski earned a bachelor's degree in chemistry, cum laude, from Yale College,[5] and a Doctor of Philosophy in biological chemistry from the Massachusetts Institute of Technology[6] (1979) with a thesis on D-amino acid dehydrogenase evolution, supervised by Christopher T.
[citation needed] Olsiewski directed commercial development for in vitro diagnostic products at Enzo Biochem, (NYSE:ENZ), a biotechnology company focused on the manipulation and modification of nucleic acids to produce therapeutic and diagnostic products.
She was a member of the Committee on Advances in Technology and the Prevention of Their Application to Next Generation Biowarfare Threats, which produced the National Research Counsel Report “Globalization, Biosecurity, and the Future of Life Sciences”[13] (2006).
Her most cited papers, according to Google Scholar:[14] In 1995, Olsiewski won the MIT Henry B. Kane '24 Award, which is given in recognition of exception service and accomplishments in the area of fundraising.